Chu, William W <br/><br/>
Bivalirudin versus unfractionated heparin in patients undergoing percutaneous coronary intervention after acute myocardial infarction.  [electronic resource] 

 -  Cardiovascular revascularization medicine : including molecular interventions   
 - 132-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1553-8389 
<br/><br/><label>Standard No.: </label>10.1016/j.carrev.2006.04.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angioplasty, Balloon, Coronary--adverse effects<br/>Anticoagulants--therapeutic use<br/>Clopidogrel<br/>Coronary Angiography<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Heparin--analogs & derivatives<br/>Hirudins<br/>Humans<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--diagnostic imaging<br/>Peptide Fragments--therapeutic use<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Postoperative Complications--diagnostic imaging<br/>Recombinant Proteins--therapeutic use<br/>Research Design<br/>Ticlopidine--analogs & derivatives<br/>Time Factors<br/>Treatment Outcome